American multinational medical technology company GE HealthCare extends its collaboration with Swedish brand Elekta, a leader in radiation therapy, to expand access to precision radiation therapy solutions for the Indian market. It aims to provide hospitals with a comprehensive offering across diagnostics and treatment for cancer patients who require radiation therapy.

Radiation therapy is an important component of cancer treatment with more than 50% of patients requiring radiotherapy as part of cancer care. The World Health Organisation (WHO) recommends one medical linear accelerator, (a radiotherapy equipment used in treating cancers) per million population in developing countries.

India currently only has availability of  0.4 per million people reducing access to quality care necessary to enhance patient outcomes. Combining GE HealthCare diagnostic solutions with Elekta radiation therapy solutions will result in a compelling offering for hospitals and ultimately, their patients.

GE HealthCare’s collaboration with Elekta in India is a testament to the company’s commitment to improving cancer outcomes with multiple partners and providers. As a leading innovator of precision radiation therapy solutions, Elekta’s treatment modalities demand superior precision and accuracy in delivering radiation to the tumor while protecting surrounding healthy tissue and organs. 

Picture caption (From left to right):

• Chaitanya Sarawate, President & CEO, GE HealthCare South Asia and Managing Director, Wipro GE Healthcare
• Manikandan Bala, Senior Vice President, TIMEA & Asia Pacific and Managing Director, India & South Africa, Elekta